Form 4: Insulet Director Robert Huffines Acquires Stock

Director Robert Huffines of Insulet Corporation acquired 144 shares of common stock through a deferred compensation plan.

Summary

• Robert Huffines, a Director at Insulet Corporation, acquired 144 shares of common stock on June 30, 2026.
• The acquisition was made under the Company's Deferred Compensation Plan for Non-Employee Directors, where shares are received in lieu of cash compensation.
• The transaction price was $159.79 per share.
• Following this transaction, Mr. Huffines beneficially owns 2,442 shares of common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a routine transaction related to director compensation rather than a significant strategic event or financial performance indicator.

Positives

• Director acquisition of company stock can signal confidence in the company's future prospects.
• The acquisition was made through a deferred compensation plan, indicating a long-term incentive structure for directors.

Future Outlook

The filing does not contain forward-looking statements or guidance.

Industry Context

StockSavvy.ai notes that director stock acquisitions, particularly through deferred compensation plans, are common within the medical device industry as a way to align executive and director interests with shareholders.

Stakeholder Impact

• Shareholders: The acquisition by a director may be viewed positively as a sign of confidence in the company's value.

Key Dates

Keywords

Insulet Corporation, PODD, Form 4, Insider Trading, Director Compensation, Deferred Compensation, Common Stock